Current understanding of metformin effect on the control of hyperglycemia in diabetes

169Citations
Citations of this article
289Readers
Mendeley users who have this article in their library.

Abstract

Metformin is a first-line oral anti-diabetic agent that has been used clinically to treat patients with type 2 diabetes for over 60 years. Due to its efficacy in therapy and affordable price, metformin is taken by more than 150 million people each year. Metformin improves hyperglycemia mainly through the suppression of hepatic gluconeogenesis along with the improvement of insulin signaling. However, its mechanism of action remains partially understood and controversial, especially in regard to the role of AMPK in metformin's action and the mechanism of AMPK activation. In this review, we discuss recent advances in the understanding of metformin's suppression of hepatic glucose production and the mechanism related to the improvement of insulin signaling.

Cite

CITATION STYLE

APA

An, H., & He, L. (2016). Current understanding of metformin effect on the control of hyperglycemia in diabetes. Journal of Endocrinology. BioScientifica Ltd. https://doi.org/10.1530/JOE-15-0447

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free